Bactroban 2% nasal ointment 3g/ Bactroban 2% cream 15g - Beecham Group plc trading as GlaxoSmithKline UK (CLDA (15)A/06) - 24 August 2015

Beecham Group plc trading as GlaxoSmithKline UK is recalling specific batches of Bactroban 2% Nasal Ointment 3g and Bactroban 2% Cream 15g.

Product information

CLDA number

CLDA (15)A/06

MDR number

59-07/15

Company name

Beecham Group plc trading as GlaxoSmithKline UK

Product description

Bactroban 2% Nasal Ointment 3g - PL 00038/0347

Bactroban 2% Cream 15g - PL 00038/0372

Batch number/ expiry

Bactroban 2% Nasal Ointment 3g
Batch number Expiry date
C683302 9 June 2017
C694256 25 August 2017
C699242 2 October 2017
C700830 13 October 2017
C722794 13 April 2018
Bactroban 2% Cream 15g
Batch number Expiry date
C680732 16 November 2015
C703976 2 May 2016
C704955 12 May 2016
C725156 10 October 2016

Brief description of problem

Wholesaler level recall due to potential risk of physical contamination with foreign materials associated with the manufacturing of the active substance, mupirocin calcium.

No complaints or adverse reactions relating to this issue have been received by the company to date.

Wholesalers are asked to return any affected stock to their supplier.

Company contact for medical information enquiries

GlaxoSmithKline UK Medical Information Department
Telephone: 0800 221441, option 2

Email: ukmedinfo@gsk.com

Advice for healthcare professionals and patients

This recall is to wholesalers only to prevent further distribution of the affected batches.

No complaints or adverse reactions relating to this issue have been received by the company to date.

Due to the very low level of risk, pharmacies may continue to dispense any stock and patients should continue using the products.

If you do experience any adverse reactions, please report them via the Yellow Card Scheme. You can also download the Yellow Card smartphone app from the iTunes App Store or Google Play for your IOS or Android device.

Contact GlaxoSmithKline UK Medical Information Department on 0800 221441, option 2, if you have any concerns with the product.

Updates to this page

Published 24 August 2015